RIC is an established method for reducing ischemic and reperfusive damage in various organs, including the heart and the brain.
20 The protective effect is assumed to be mediated by neuronal stimulation and/or substances released to the systemic circulation from a limb, such as the arm, exposed to controlled transient ischemia.
21 The substances are assumed to reduce postischemic hypoperfusion in target organs elsewhere in the body,
5 and can therefore be expected to affect vessel diameters in these organs including the eye.
The purpose of the present study was to investigate whether the diameter of normal retinal vessels might potentially be used as an in vivo marker of RIC. The study used an RIC protocol with four ischemic cycles in one arm, each lasting 5 minutes, which has previously been shown to induce optimal RIC in the heart.
19,21,22 The lack of carryover effects between the resting phases separating the flicker and exercise periods supports that, with the chosen design, the effects of these interventions on retinal vessel diameters had been independent. However, it cannot be excluded that this protocol should be modified in future studies to optimize an effect of RIC in the retina. Additionally, it should be investigated whether the observed response depends on sex or age, which has been shown for pressure autoregulation.
23
Previous studies suggest that the effects of RIC can be divided into two phases.
24–26 An “early phase” lasting up to 4 hours after the controlled ischemia may potentially involve effects of purins, such as adenosine and ATP, nitric oxide synthase (NOS) products, protein kinase C, and reactive oxygen species.
27–29 A “delayed phase” 24 to 48 hours after the ischemia depends on the expression of genes coding for inducible NOS and compounds protecting cells from apoptosis.
30–32 The present study aimed at studying possible diameter changes in normal persons corresponding to the early phase during which RIC has previously been shown to change blood flow in the heart and the brain.
33–35 Diameter measurements were performed immediately after the controlled ischemia in an arm to assess transient effects of changes in blood pressure, heart rate, and autonomic nervous activity induced by the ischemia, and again after 1 hour to assess the effects of humoral factors other than volatile signaling molecules released during ischemia.
36,37 The diameters were measured both in arterioles that are the main resistance vessels determining perfusion, and in venules in which the diameter can be affected by substances released by the metabolism in the tissue drained by the vessel.
11 Although significant effects were observed in the diameter of larger retinal vessels, it cannot be excluded that the diameter of vessels in the retinal microcirculation had also been affected to influence retinal blood flow.
38,39 This should be the subject of future investigations.
The baseline diameter of the arterioles was unchanged for at least 1 hour after RIC, which is in accordance with previous findings
32 and indicates that RIC does not release substances to affect blood flow in normal resistance vessels during the early postischemic period. This lack of diameter response in arterioles is appropriate, because transient ischemia may occur under normal physiological conditions, such as during isometric exercise or when limbs are transiently compressed (e.g., in recumbent positions during sleep), and such activities should not affect perfusion in other organs. However, it cannot be excluded that changes in the diameter of retinal arterioles might occur in the delayed phase of ischemic conditioning beyond the duration of the present study. This could be supported by observations of increased cerebral blood flow at 4 and 6 hours post RIC in experimental animals.
35 The observed vasoconstriction restricted to retinal venules may be a direct effect of compounds released from the ischemic arm on these vessels. This confirms a study showing a different response potential to vasoactive compounds in retinal arterioles and venules that involved effects of both nitric oxide and cyclo-oxygenase (COX) products.
40 Alternatively, the effect on the venules might be due to inactive mediators released from the ischemic arm that had been activated during the passage of the retinal microcirculation.
The observation of a more than 20% increase in MAP during isometric exercise and a consequent constriction of retinal arterioles of approximately 4% is consistent with findings of previous studies.
18,23 Immediately after RIC, isometric exercise induced a similar increase in MAP but a significantly smaller constriction of the arterioles that may have increased retinal perfusion,
5 which is in accordance with observations from the brain using laser Doppler imaging technique.
35 The findings might potentially be related to anti-inflammatory effects. Thus, the response is similar to what has been observed after topical administration of COX inhibitors,
41 and several studies have shown that brief episodes of remote ischemia can suppress the expression of proinflammatory genes and attenuate apoptosis.
42–44 Future studies should investigate the influence of specific COX products on the contractility of retinal arterioles after remote ischemia.
The observed dilatation of retinal arterioles and venules induced by flicker stimulation was similar to observations in previous studies,
38,45–47 and was unaffected by a simultaneous increase in the arterial blood pressure.
48 Flicker stimulation increases retinal metabolism, resulting in hypoxia, and might reflect aspects of the diameter response in retinal ischemic disease. However, the observed lack of influence of RIC on the diameter may be because flicker stimulation had induced maximal dilatation with an elimination of the potential for further dilatation induced by RIC. In future studies, it should be investigated whether the mechanisms involved in RIC are similar to those responsible for vasodilation induced by increased retinal metabolism, such as during flicker stimulation. This might point to possible mechanisms underlying RIC.
In conclusion, the present study is the first to show that transient ischemia in a limb can affect the diameter of larger retinal vessels within 1 hour after the ischemia. Future studies should aim at identifying the mediators involved in RIC, the duration of the response, and to what extent the diameter response in retinal vessels is a marker of ischemic conditioning in the body in general. Furthermore, it might be of interest to study the effects of RIC on vessel diameters and blood flow in vascular diseases characterized by retinal ischemia. This might shed further light on the pathophysiology of retinal ischemia and point to possible future interventions on vision-threatening diseases associated with retinal ischemia, such as diabetic retinopathy and retinal vein thrombosis.